Tuesday, December 10, 2019

Panacea Biotec launches generic diabetes treatment drug in India

Panacea Biotec launches generic diabetes treatment drug in India The four formulations are Vildagliptin 50 mg, Vildagliptin 50 mg Metformin HCL 500 mg, Vildagliptin 50 mg Metformin HCL 850 mg and Vildagliptin 50 mg Metformin HCL 1,000 mg, Panacea Biotec said in a filing to the BSE.

from Moneycontrol Business News https://ift.tt/2E1mLy1
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...